SLC22A8 and nonpapillary renal cell carcinoma: Second, although we concluded that SLC22A8 expression is strongly associated with immune cell infiltration and patient prognosis in ccRCC, we lack direct evidence that SLC22A8 affects prognosis through its involvement in immune infiltration.